JF
PVLA

Jump Financial’s Palvella Therapeutics PVLA Stock Holding History

Jump Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$841K Buy
+6,743
New +$703K 0.01% 1001
2021
Q4 		– Sell
-1,098
Closed -$454K – 1783
2021
Q3 		$454K Buy
+1,098
New +$382K 0.03% 509

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jump Financial's PVLA Position: Q1 2026 in Review

Jump Financial opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 6,743 shares worth $841K. The stake represents 0.01% of the portfolio and ranks #1001 among its holdings. This is a return to the name: Jump Financial previously reported a position in PVLA as recently as Q3 2021.

Jump Financial first reported a position in PVLA in Q3 2021 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Jump Financial held 6,743 shares of Palvella Therapeutics worth $841K as of Q1 2026.
  • Palvella Therapeutics was a new Jump Financial position in Q1 2026.
  • Palvella Therapeutics made up 0.01% of Jump Financial's portfolio in Q1 2026, its #1001 holding.
  • Jump Financial first reported a position in Palvella Therapeutics in Q3 2021 and has held it in 2 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.